Sun Pharmaceutical Industries logo

SUNPHARMA - Sun Pharmaceutical Industries Share Price

₹679.4 -4.0  -0.6%

Last Trade - 11:28am

Large Cap
Market Cap £16.01bn
Enterprise Value £16.14bn
Revenue £3.24bn
Position in Universe 24th / 3105
Unlock SUNPHARMA Revenue
Relative Strength (%)
1m +13.0%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.65%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
273,920 284,870 315,784 264,895 290,659 328,375 337,874 375,192 +3.7%
-20.6 +5.9 +35.5 -55.8 +21.6 +6.5 +50.4 +2.27
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, SunPharmaceutical Industries Limited revenues increased 1% toRS249.75B. Net income decreased 40% to RS20.1B. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Net incomewas offset by Exceptional items increase from RS0K toRS36.33B (expense), Employee benefits expense increase of10% to RS51.85B (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for SUNPHARMA
Graphical History


SUNPHARMA Revenue Unlock SUNPHARMA Revenue

Net Income

SUNPHARMA Net Income Unlock SUNPHARMA Revenue

Normalised EPS

SUNPHARMA Normalised EPS Unlock SUNPHARMA Revenue

PE Ratio Range

SUNPHARMA PE Ratio Range Unlock SUNPHARMA Revenue

Dividend Yield Range

SUNPHARMA Dividend Yield Range Unlock SUNPHARMA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SUNPHARMA EPS Forecasts Unlock SUNPHARMA Revenue
Profile Summary

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New Zealand and other markets. The Company offers its products to therapy areas, such as cardiology, neuro-psychiatry, gastroenterology, anti-infective, diabetology and dermatology. The Company's products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are situated in India, the United States and Brazil, among others. Its units produce generics, branded generics, specialty products, over-the-counter (OTC) products, anti-retroviral (ARVs) and APIs. They also produce intermediates in a range of dosage forms, including tablets, capsules, injectables, ointments, creams and liquids.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated March 1, 1993
Public Since January 1, 1994
No. of Shareholders: 654,242
No. of Employees: 36,000
Sector Healthcare
Industry Pharmaceuticals
Index S&P BSE 100 , S&P BSE Sensex , Nifty 50 ,
Exchange National Stock Exchange of India
Shares in Issue 2,399,334,970
Free Float (0.0%)
Eligible for
SUNPHARMA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for SUNPHARMA
Upcoming Events for SUNPHARMA
Tuesday 25th May, 2021 Estimate
Full Year 2021 Sun Pharmaceutical Industries Ltd Earnings Release
Thursday 29th July, 2021 Estimate
Q1 2022 Sun Pharmaceutical Industries Ltd Earnings Release
Friday 27th August, 2021 Estimate
Sun Pharmaceutical Industries Ltd Annual Shareholders Meeting
Monday 1st November, 2021 Estimate
Q2 2022 Sun Pharmaceutical Industries Ltd Earnings Release
Frequently Asked Questions for Sun Pharmaceutical Industries
What is the Sun Pharmaceutical Industries share price?

As of 11:28am, shares in Sun Pharmaceutical Industries are trading at ₹679.4, giving the company a market capitalisation of £16.01bn. This share price information is delayed by 15 minutes.

How has the Sun Pharmaceutical Industries share price performed this year?

Shares in Sun Pharmaceutical Industries are currently trading at ₹679.4 and the price has moved by 49.77% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sun Pharmaceutical Industries price has moved by -5.28% over the past year.

What are the analyst and broker recommendations for Sun Pharmaceutical Industries?

Of the analysts with advisory recommendations for Sun Pharmaceutical Industries, there are there are currently 14 "buy" , 1 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Sun Pharmaceutical Industries is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Sun Pharmaceutical Industries next release its financial results?

Sun Pharmaceutical Industries is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Sun Pharmaceutical Industries dividend yield?

The Sun Pharmaceutical Industries dividend yield is 0.95% based on the trailing twelve month period.

Does Sun Pharmaceutical Industries pay a dividend?

Last year, Sun Pharmaceutical Industries paid a total dividend of 6.5, and it currently has a trailing dividend yield of 0.95%. Looking ahead, Sun Pharmaceutical Industries has not announced an ex-dividend date yet.

When does Sun Pharmaceutical Industries next pay dividends?

Sun Pharmaceutical Industries has yet to annouce their ex-dividend date. The historic dividend yield on Sun Pharmaceutical Industries shares is currently 0.95%.

How do I buy Sun Pharmaceutical Industries shares?

To buy shares in Sun Pharmaceutical Industries you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sun Pharmaceutical Industries?

Shares in Sun Pharmaceutical Industries are currently trading at ₹679.4, giving the company a market capitalisation of £16.01bn.

Where are Sun Pharmaceutical Industries shares listed? Where are Sun Pharmaceutical Industries shares listed?

Here are the trading details for Sun Pharmaceutical Industries:

Country of listing: India
Exchange: NSI
Ticker Symbol: SUNPHARMA
What kind of share is Sun Pharmaceutical Industries?

Based on an overall assessment of its quality, value and momentum, Sun Pharmaceutical Industries is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Sun Pharmaceutical Industries share price forecast 2021?

Shares in Sun Pharmaceutical Industries are currently priced at ₹679.4. At that level they are trading at 1.84% premium to the analyst consensus target price of 0.00.

Analysts covering Sun Pharmaceutical Industries currently have a consensus Earnings Per Share (EPS) forecast of 25.001 for the next financial year.

How can I tell whether the Sun Pharmaceutical Industries share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sun Pharmaceutical Industries. Over the past six months, the relative strength of its shares against the market has been 12.42%. At the current price of ₹679.4, shares in Sun Pharmaceutical Industries are trading at 22.44% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sun Pharmaceutical Industries PE Ratio?

The Sun Pharmaceutical Industries PE ratio based on its reported earnings over the past 12 months is 31.04. The shares are currently trading at ₹679.4.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Sun Pharmaceutical Industries?

Sun Pharmaceutical Industries's management team is headed by:

Sudhir Valia - NED
Israel Makov - NEC
Rekha Sethi - NID
Uday Baldota - CEX
C. Muralidharan - CFO
Vivek Sehgal - NID
Gautam Doshi - NID
Abhay Gandhi - CEX
Pradeep Sanghvi - EVP
Sapna Purohit - SVP
Azadar Khan - SVP
Anilkumar Jain - CEX
Kirti Ganorkar - CEX
Jila Breeze - SVP
Atanu Roy - SVP
Who are the major shareholders of Sun Pharmaceutical Industries?

Here are the top five shareholders of Sun Pharmaceutical Industries based on the size of their shareholding:

Shanghvi (Dilip Shantilal) Individual Investor
Percentage owned: 9.6% (230.3m shares)
Life Insurance Corporation of India Insurance Company
Percentage owned: 6.79% (162.9m shares)
ICICI Prudential Asset Management Co. Ltd. Investment Advisor
Percentage owned: 3.12% (75.0m shares)
Shanghvi Finance Pvt. Ltd. Corporation
Percentage owned: 2.26% (54.2m shares)
SBI Funds Management Pvt. Ltd. Investment Advisor
Percentage owned: 1.87% (44.9m shares)
Similar to SUNPHARMA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.